The sub-phenotyping of hypertension may suggest that dietary potassium may be more effective in patients with endothelial dysfunction-dominant hypertensive subtypes compared with volume-dependent hypertension (e.g., low-renin and salt-sensitive) and may call for K+ supplementation studies stratified by hypertension subtype as a refining clinical guideline. This evidence concerns the gene REN and Hypertension.